[1]
Weaam F. Hussien et al. 2025. Investigation of Methylglyoxal, soluble Receptor for Advanced Glycation End-products, and Malondialdehyde in Type 2 Diabetes Mellitus with and Without Cardiovascular Risk Factors. Diyala Journal of Medicine. 29, 1 (Oct. 2025), 99–110. DOI:https://doi.org/10.26505/djm.v29i1.1501.